🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
VLA
$VLA.PA
🔒 EuropeValneva SE
AVG HISTORICAL GAP
+3.61%
MAX GAP RECORD
+12.88%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $VLA.PA
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$VLA.PA
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 13, 2026 Earnings Release 2026-08-13 (AFTER CLOSE) |
+9.16%
|
| May 13, 2026 Earnings Release 2026-05-13 (AFTER CLOSE) |
+0.08%
|
| Mar 17, 2026 Earnings Release 2026-03-17 (AFTER CLOSE) |
-3.60%
|
| Nov 20, 2025 Earnings Release 2025-11-20 (AFTER CLOSE) |
-2.44%
|
| Aug 12, 2025 Earnings Release 2025-08-12 (BEFORE OPEN) |
+5.66%
|
| Mar 20, 2025 Earnings Release 2025-03-20 (BEFORE OPEN) |
+3.71%
|
| Nov 07, 2024 Earnings Release 2024-11-07 (AFTER CLOSE) |
+0.32%
|
| Aug 13, 2024 Earnings Release 2024-08-13 (BEFORE OPEN) |
+6.70%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
4.5%
Bullish Gaps (8)
Bearish Gaps (2)
Neutral / Flat (3)
📖 Intelligence Summary
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. It currently provides three proprietary travel vaccines: IXIARO, DUKORAL, and IXCHIQ. The IXIARO is an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗